Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 30,777 | 20,817 | 8,503 | 2,199 | 2,867 |
| Depreciation Amortization | 4,840 | 3,877 | 4,137 | 4,116 | 4,186 |
| Income taxes - deferred | -29 | -179 | -1,063 | 962 | 600 |
| Accounts payable and accrued liabilities | -208 | 1,707 | 21 | -680 | -695 |
| Other Working Capital | 863 | 9,784 | 2,855 | 1,779 | -3,694 |
| Other Operating Activity | 1,940 | -528 | 1,490 | 1,575 | 804 |
| Operating Cash Flow | $38,183 | $35,478 | $15,943 | $9,951 | $4,068 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,923 | -4,516 | -2,921 | -6,549 | -2,491 |
| Net Acquisitions | -2,140 | -5,341 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | 5 |
| Investing Cash Flow | $-9,063 | $-9,857 | $-2,921 | $-6,549 | $-2,486 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | -2,913 | -1,185 | -3,071 | 4,363 |
| Debt Repayment | N/A | -6,091 | -2,003 | N/A | -1,500 |
| Common Stock Issued | 1,418 | 3,504 | 1,129 | N/A | 68 |
| Common Stock Repurchased | -34,941 | -8,237 | -7,853 | -33 | -2,989 |
| Financing Cash Flow | $-33,523 | $-13,737 | $-9,912 | $-3,104 | $-58 |
| Exchange Rate Effect | 505 | 395 | 1,111 | -733 | -35 |
| Beginning Cash Position | 18,965 | 6,686 | 2,465 | 2,900 | 1,411 |
| End Cash Position | 15,067 | 18,965 | 6,686 | 2,465 | 2,900 |
| Net Cash Flow | $-3,898 | $12,279 | $4,221 | $-435 | $1,489 |
| Free Cash Flow | |||||
| Operating Cash Flow | 38,183 | 35,478 | 15,943 | 9,951 | 4,068 |
| Capital Expenditure | -6,952 | -4,564 | -2,966 | -6,602 | -5,265 |
| Free Cash Flow | 31,231 | 30,914 | 12,977 | 3,349 | -1,197 |